Oscar Fernandez-Capetillo

11PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersProcess control and simulationHaematological tumoursProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 04, 2026
Exploiting a purine imbalance to target KRAS mutant pancreatic adenocarcinomas.

Jorge Mota-Pino, Oscar Fernandez-Capetillo

|Oct 25, 2024
Cyclophilin D plays a critical role in the survival of senescent cells.

Margherita Protasoni, Vanessa López-Polo, Camille Stephan-Otto Attolini

|Sep 28, 2024
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis.

Matilde Murga, Gema Lopez-Pernas, Robert Soliva

|Nov 02, 2022
Emerging concepts in drug discovery for cancer therapy.

Matilde Murga, Oscar Fernandez-Capetillo

|Sep 05, 2022
New regulators of the tetracycline-inducible gene expression system identified by chemical and genetic screens.

Valeria Colicchia, Maria Häggblad, Oleksandra Sirozh

|Jul 21, 2022
Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells.

Laura Sanchez-Burgos, Belén Navarro-González, Santiago García-Martín

Pageof 2

Frequent Collaborators

2 joint publications

Antonio Galarreta

1 joint publications

Pablo Valledor

1 joint publications

Javier Muñoz

1 joint publications

Marcos Malumbres